These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 2943756

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center study.
    Carr BR, Breslau NA, Givens C, Byrd W, Barnett-Hamm C, Marshburn PB.
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1169-78. PubMed ID: 7714086
    [Abstract] [Full Text] [Related]

  • 5. Differential suppression of testosterone and estradiol in hirsute women with the superactive gonadotropin-releasing hormone agonist leuprolide.
    Rittmaster RS.
    J Clin Endocrinol Metab; 1988 Oct; 67(4):651-5. PubMed ID: 3138274
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dose-dependent inhibition of pituitary-ovarian function during administration of a gonadotropin-releasing hormone agonistic analog (nafarelin).
    Monroe SE, Blumenfeld Z, Andreyko JL, Schriock E, Henzl MR, Jaffe RB.
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1334-41. PubMed ID: 2946710
    [Abstract] [Full Text] [Related]

  • 9. Estrogen replacement does not potentiate gonadotropin-releasing hormone agonist-induced androgen suppression in treatment of hirsutism.
    Tiitinen A, Simberg N, Stenman UH, Ylikorkala O.
    J Clin Endocrinol Metab; 1994 Aug; 79(2):447-51. PubMed ID: 8045961
    [Abstract] [Full Text] [Related]

  • 10. The stimulatory and down-regulatory effects of a gonadotropin-releasing hormone agonist in man.
    Heber D, Bhasin S, Steiner B, Swerdloff RS.
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1084-8. PubMed ID: 6233295
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism.
    Bertoli A, Fusco A, Magnani A, Marini MA, Di Daniele N, Gatti S, Lauro R.
    Exp Clin Endocrinol Diabetes; 1995 Jun; 103(1):15-20. PubMed ID: 7621099
    [Abstract] [Full Text] [Related]

  • 13. Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism.
    De Leo V, Fulghesu AM, la Marca A, Morgante G, Pasqui L, Talluri B, Torricelli M, Caruso A.
    Gynecol Endocrinol; 2000 Dec; 14(6):411-6. PubMed ID: 11228061
    [Abstract] [Full Text] [Related]

  • 14. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
    Calogero AE, Macchi M, Montanini V, Mongioi A, Maugeri G, Vicari E, Coniglione F, Sipione C, D'Agata R.
    J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
    [Abstract] [Full Text] [Related]

  • 15. Comparison of a gonadotropin-releasing hormone agonist and a low dose oral contraceptive given alone or together in the treatment of hirsutism.
    Heiner JS, Greendale GA, Kawakami AK, Lapolt PS, Fisher M, Young D, Judd HL.
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3412-8. PubMed ID: 8530574
    [Abstract] [Full Text] [Related]

  • 16. Detection of functional ovarian hyperandrogenism in women with androgen excess.
    Ehrmann DA, Rosenfield RL, Barnes RB, Brigell DF, Sheikh Z.
    N Engl J Med; 1992 Jul 16; 327(3):157-62. PubMed ID: 1319000
    [Abstract] [Full Text] [Related]

  • 17. Physiological estrogen replacement may enhance the effectiveness of the gonadotropin-releasing hormone agonist in the treatment of hirsutism.
    Carmina E, Janni A, Lobo RA.
    J Clin Endocrinol Metab; 1994 Jan 16; 78(1):126-30. PubMed ID: 8288696
    [Abstract] [Full Text] [Related]

  • 18. A new test of combined pituitary-testicular function using the gonadotropin-releasing hormone agonist nafarelin in the differentiation of gonadotropin deficiency from delayed puberty: pilot studies.
    Ehrmann DA, Rosenfield RL, Cuttler L, Burstein S, Cara JF, Levitsky LL.
    J Clin Endocrinol Metab; 1989 Nov 16; 69(5):963-7. PubMed ID: 2529266
    [Abstract] [Full Text] [Related]

  • 19. A comparative study of a gonadotropin-releasing hormone agonist and finasteride on idiopathic hirsutism.
    Bayhan G, Bahçeci M, Demirkol T, Ertem M, Yalinkaya A, Erden AC.
    Clin Exp Obstet Gynecol; 2000 Nov 16; 27(3-4):203-6. PubMed ID: 11214952
    [Abstract] [Full Text] [Related]

  • 20. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
    Carmina E, Lobo RA.
    Obstet Gynecol; 1991 Nov 16; 78(5 Pt 1):845-9. PubMed ID: 1833685
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.